237 related articles for article (PubMed ID: 16790356)
1. The effects of a dominant connexin32 mutant in myelinating Schwann cells.
Jeng LJ; Balice-Gordon RJ; Messing A; Fischbeck KH; Scherer SS
Mol Cell Neurosci; 2006 Jul; 32(3):283-98. PubMed ID: 16790356
[TBL] [Abstract][Full Text] [Related]
2. Transgenic expression of human connexin32 in myelinating Schwann cells prevents demyelination in connexin32-null mice.
Scherer SS; Xu YT; Messing A; Willecke K; Fischbeck KH; Jeng LJ
J Neurosci; 2005 Feb; 25(6):1550-9. PubMed ID: 15703409
[TBL] [Abstract][Full Text] [Related]
3. Connexin32 and X-linked Charcot-Marie-Tooth disease.
Bone LJ; Deschênes SM; Balice-Gordon RJ; Fischbeck KH; Scherer SS
Neurobiol Dis; 1997; 4(3-4):221-30. PubMed ID: 9361298
[TBL] [Abstract][Full Text] [Related]
4. X-linked Charcot-Marie-Tooth disease and connexin32.
Fischbeck KH; Abel A; Lin GS; Scherer SS
Ann N Y Acad Sci; 1999 Sep; 883():36-41. PubMed ID: 10586227
[TBL] [Abstract][Full Text] [Related]
5. Prenylation-defective human connexin32 mutants are normally localized and function equivalently to wild-type connexin32 in myelinating Schwann cells.
Huang Y; Sirkowski EE; Stickney JT; Scherer SS
J Neurosci; 2005 Aug; 25(31):7111-20. PubMed ID: 16079393
[TBL] [Abstract][Full Text] [Related]
6. Functional analysis of connexin-32 mutants associated with X-linked dominant Charcot-Marie-Tooth disease.
Wang HL; Chang WT; Yeh TH; Wu T; Chen MS; Wu CY
Neurobiol Dis; 2004 Mar; 15(2):361-70. PubMed ID: 15006706
[TBL] [Abstract][Full Text] [Related]
7. Analysis of connexin expression during mouse Schwann cell development identifies connexin29 as a novel marker for the transition of neural crest to precursor cells.
Li J; Habbes HW; Eiberger J; Willecke K; Dermietzel R; Meier C
Glia; 2007 Jan; 55(1):93-103. PubMed ID: 17024657
[TBL] [Abstract][Full Text] [Related]
8. Expression pattern and functional characterization of connexin29 in transgenic mice.
Eiberger J; Kibschull M; Strenzke N; Schober A; Büssow H; Wessig C; Djahed S; Reucher H; Koch DA; Lautermann J; Moser T; Winterhager E; Willecke K
Glia; 2006 Apr; 53(6):601-11. PubMed ID: 16435366
[TBL] [Abstract][Full Text] [Related]
9. Altered gene expression in Schwann cells of connexin32 knockout animals.
Nicholson SM; Gomès D; de Néchaud B; Bruzzone R
J Neurosci Res; 2001 Oct; 66(1):23-36. PubMed ID: 11598999
[TBL] [Abstract][Full Text] [Related]
10. Connexin32 mutations cause loss of function in Schwann cells and oligodendrocytes leading to PNS and CNS myelination defects.
Sargiannidou I; Vavlitou N; Aristodemou S; Hadjisavvas A; Kyriacou K; Scherer SS; Kleopa KA
J Neurosci; 2009 Apr; 29(15):4736-49. PubMed ID: 19369543
[TBL] [Abstract][Full Text] [Related]
11. Intraneural GJB1 gene delivery improves nerve pathology in a model of X-linked Charcot-Marie-Tooth disease.
Sargiannidou I; Kagiava A; Bashiardes S; Richter J; Christodoulou C; Scherer SS; Kleopa KA
Ann Neurol; 2015 Aug; 78(2):303-16. PubMed ID: 26010264
[TBL] [Abstract][Full Text] [Related]
12. Connexin29 is uniquely distributed within myelinating glial cells of the central and peripheral nervous systems.
Altevogt BM; Kleopa KA; Postma FR; Scherer SS; Paul DL
J Neurosci; 2002 Aug; 22(15):6458-70. PubMed ID: 12151525
[TBL] [Abstract][Full Text] [Related]
13. Intrathecal gene therapy in mouse models expressing CMT1X mutations.
Kagiava A; Karaiskos C; Richter J; Tryfonos C; Lapathitis G; Sargiannidou I; Christodoulou C; Kleopa KA
Hum Mol Genet; 2018 Apr; 27(8):1460-1473. PubMed ID: 29462293
[TBL] [Abstract][Full Text] [Related]
14. Golgi-retained Cx32 mutants interfere with gene addition therapy for CMT1X.
Kyriakoudi S; Sargiannidou I; Kagiava A; Olympiou M; Kleopa KA
Hum Mol Genet; 2017 May; 26(9):1622-1633. PubMed ID: 28334782
[TBL] [Abstract][Full Text] [Related]
15. Gene expression profiling studies in regenerating nerves in a mouse model for CMT1X: uninjured Cx32-knockout peripheral nerves display expression profile of injured wild type nerves.
Freidin M; Asche-Godin S; Abrams CK
Exp Neurol; 2015 Jan; 263():339-49. PubMed ID: 25447941
[TBL] [Abstract][Full Text] [Related]
16. A second alternative transcript of the gap junction gene connexin32 is expressed in murine Schwann cells and modulated in injured sciatic nerve.
Söhl G; Gillen C; Bosse F; Gleichmann M; Müller HW; Willecke K
Eur J Cell Biol; 1996 Mar; 69(3):267-75. PubMed ID: 8900491
[TBL] [Abstract][Full Text] [Related]
17. Unique distributions of the gap junction proteins connexin29, connexin32, and connexin47 in oligodendrocytes.
Kleopa KA; Orthmann JL; Enriquez A; Paul DL; Scherer SS
Glia; 2004 Sep; 47(4):346-57. PubMed ID: 15293232
[TBL] [Abstract][Full Text] [Related]
18. How do mutations in GJB1 cause X-linked Charcot-Marie-Tooth disease?
Kleopa KA; Abrams CK; Scherer SS
Brain Res; 2012 Dec; 1487():198-205. PubMed ID: 22771394
[TBL] [Abstract][Full Text] [Related]
19. Cellular mechanisms of connexin32 mutations associated with CNS manifestations.
Kleopa KA; Yum SW; Scherer SS
J Neurosci Res; 2002 Jun; 68(5):522-34. PubMed ID: 12111842
[TBL] [Abstract][Full Text] [Related]
20. Altered connexin expression after peripheral nerve injury.
Chandross KJ; Kessler JA; Cohen RI; Simburger E; Spray DC; Bieri P; Dermietzel R
Mol Cell Neurosci; 1996 Jun; 7(6):501-18. PubMed ID: 8875432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
